Your browser doesn't support javascript.
loading
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.
Parks, K Rachael; MacCamy, Anna J; Trichka, Josephine; Gray, Matthew; Weidle, Connor; Borst, Andrew J; Khechaduri, Arineh; Takushi, Brittany; Agrawal, Parul; Guenaga, Javier; Wyatt, Richard T; Coler, Rhea; Seaman, Michael; LaBranche, Celia; Montefiori, David C; Veesler, David; Pancera, Marie; McGuire, Andrew; Stamatatos, Leonidas.
Affiliation
  • Parks KR; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA.
  • MacCamy AJ; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Trichka J; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gray M; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Weidle C; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Borst AJ; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Khechaduri A; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Takushi B; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Agrawal P; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Guenaga J; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, San Diego, CA, USA.
  • Wyatt RT; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, San Diego, CA, USA.
  • Coler R; Department of Global Health, University of Washington, Seattle, WA, USA; Infectious Disease Research Institute, Seattle, WA, USA.
  • Seaman M; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • LaBranche C; Laboratory for AIDS Vaccine Research and Development, Duke University, Durham, NC, USA.
  • Montefiori DC; Laboratory for AIDS Vaccine Research and Development, Duke University, Durham, NC, USA.
  • Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Pancera M; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA. Electronic address: mpancera@fredhutch.org.
  • McGuire A; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: amcguire@fredhutch.org.
  • Stamatatos L; Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: lstamata@fredhutch.org.
Cell Rep ; 29(10): 3060-3072.e7, 2019 12 03.
Article in En | MEDLINE | ID: mdl-31801073
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Antibodies / HIV-1 / Antibodies, Neutralizing / Broadly Neutralizing Antibodies / Antibodies, Monoclonal Limits: Animals Language: En Journal: Cell Rep Year: 2019 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Antibodies / HIV-1 / Antibodies, Neutralizing / Broadly Neutralizing Antibodies / Antibodies, Monoclonal Limits: Animals Language: En Journal: Cell Rep Year: 2019 Document type: Article Affiliation country: United States